The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system was named a top invention of 2023. The first implantation ...

Munich, Germany - In a recent study evaluating the safety of airport metal detectors on implantable cardioverter devices (ICDs) and pacemakers, German investigators conclude that airport security ...

Big news comes in a very small package for the more than 200,000 Americans who get a pacemaker each year to treat slow or irregular heart rhythms. Last week, the U.S. Food and Drug Administration ...

CHICAGO — One person’s used pacemaker is another person’s treasure. A program to refurbish used pacemakers could expand access to the lifesaving devices. In a clinical trial of nearly 300 people, ...

Though a Northwestern-developed quarter-size dissolvable pacemaker worked well in pre-clinical animal studies, cardiac surgeons asked if it was possible to make the device smaller. To reduce the size ...

CHICAGO -- Secondhand permanent pacemaker use in poorer countries, following thorough cleaning and repackaging, has not resulted in patient harm so far, according to the My Heart Your Heart trialists.

Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam ...